Both in Pharmaceuticals
Viridian Therapeutics vs Amylyx Pharmaceuticals
Over the past year VRDN returned +28.8% and AMLX returned +114.0%; their daily moves had a correlation of 0.26.
VRDN +28.8% AMLX +114.0%Growth of $1, one year, split-adjusted
| Metric | VRDN | AMLX |
|---|---|---|
| Price | $29.06 | $29.40 |
| Market cap | $3.29B | $3.69B |
| Today | +15.53% | +0.68% |
| 1 month | +59.5% | +4.9% |
| 6 months | +65.7% | +83.1% |
| Year to date | −6.6% | +143.4% |
| 1 year | +25.5% | +116.2% |
| Revenue growth (YoY) | +278.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −39726.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 46.3× | — |
| Net cash | $625.7M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 55.5% | 112.2% |
| Short % of float | 18.5% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).